Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals
- PMID: 34210371
- PMCID: PMC8387684
- DOI: 10.1017/S0950268821001515
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals
Erratum in
-
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.Epidemiol Infect. 2021 Sep 14;149:e203. doi: 10.1017/S095026882100203X. Epidemiol Infect. 2021. PMID: 34517936 Free PMC article. No abstract available.
Abstract
There is a paucity of evidence about the prevalence and risk factors for symptomatic infection among children. This study aimed to describe the prevalence of symptomatic coronavirus disease 2019 (COVID-19) and its risk factors in children and adolescents aged 0-18 years in Qatar. We conducted a cross-sectional study of all children aged 0-18 years diagnosed with COVID-19 using polymerase chain reaction in Qatar during the period 1st March to 31st July 2020. A generalised linear model with a binomial family and identity link was used to assess the association between selected factors and the prevalence of symptomatic infection. A total of 11 445 children with a median age of 8 years (interquartile range (IQR) 3-13 years) were included in this study. The prevalence of symptomatic COVID-19 was 36.6% (95% confidence interval (CI) 35.7-37.5), and it was similar between children aged <5 years (37.8%), 5-9 years (34.3%) and 10 + years (37.3%). The most frequently reported symptoms among the symptomatic group were fever (73.5%), cough (34.8%), headache (23.2%) and sore throat (23.2%). Fever (82.8%) was more common in symptomatic children aged <5 years, while cough (38.7%) was more prevalent in those aged 10 years or older, compared to other age groups. Variables associated with an increased risk of symptomatic infection were; contact with confirmed cases (RD 0.21; 95% CI 0.20-0.23; P = 0.001), having visited a health care facility (RD 0.54; 95% CI 0.45-0.62; P = 0.001), and children aged under 5 years (RD 0.05; 95% CI 0.02-0.07; P = 0.001) or aged 10 years or older (RD 0.04; 95% CI 0.02-0.06; P = 0.001). A third of the children with COVID-19 were symptomatic with a higher proportion of fever in very young children and a higher proportion of cough in those between 10 and 18 years of age.
Keywords: Children; Qatar; symptomatic COVID-19.
Conflict of interest statement
None.
Figures
Similar articles
-
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.Epidemiol Infect. 2021 Sep 14;149:e203. doi: 10.1017/S095026882100203X. Epidemiol Infect. 2021. PMID: 34517936 Free PMC article. No abstract available.
-
Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: a case series in Sinaloa.Bol Med Hosp Infant Mex. 2021;78(1):18-23. doi: 10.24875/BMHIM.200002021. Bol Med Hosp Infant Mex. 2021. PMID: 33661874 English.
-
Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant.Clin Infect Dis. 2022 Sep 30;75(7):1131-1139. doi: 10.1093/cid/ciac112. Clin Infect Dis. 2022. PMID: 35271694 Free PMC article.
-
Infección por el nuevo coronavirus 2019 en niños.Rev Peru Med Exp Salud Publica. 2020 Apr-Jun;37(2):335-340. doi: 10.17843/rpmesp.2020.372.5439. Epub 2020 Aug 28. Rev Peru Med Exp Salud Publica. 2020. PMID: 32876226 Review. Spanish.
-
Ear, Nose, and Throat Manifestations of COVID-19 in Children.Pediatr Ann. 2021 Jul;50(7):e277-e281. doi: 10.3928/19382359-20210613-01. Epub 2021 Jul 1. Pediatr Ann. 2021. PMID: 34264800 Review.
Cited by
-
Main changes in the "COVID-19 in paediatrics" clinical practice guideline.An Pediatr (Engl Ed). 2022 Aug;97(2):129.e1-129.e8. doi: 10.1016/j.anpede.2022.06.006. Epub 2022 Jul 7. An Pediatr (Engl Ed). 2022. PMID: 35871151 Free PMC article.
-
[Main changes in the «COVID-19 in paediatrics» clinical practice guideline].An Pediatr (Barc). 2022 Aug;97(2):129.e1-129.e8. doi: 10.1016/j.anpedi.2022.06.015. Epub 2022 Jun 28. An Pediatr (Barc). 2022. PMID: 35782910 Free PMC article. Spanish.
-
Epidemiology and clinical features of SARS-CoV-2 infection in children and adolescents in the pre-Omicron era: A global systematic review and meta-analysis.J Glob Health. 2024 Mar 1;14:05003. doi: 10.7189/jogh.14.05003. J Glob Health. 2024. PMID: 38419461 Free PMC article.
-
Clinical epidemiology of COVID-19 among hospitalized children in rural western Kenya.PLOS Glob Public Health. 2023 Jun 14;3(6):e0002011. doi: 10.1371/journal.pgph.0002011. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37315023 Free PMC article.
-
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.Epidemiol Infect. 2021 Sep 14;149:e203. doi: 10.1017/S095026882100203X. Epidemiol Infect. 2021. PMID: 34517936 Free PMC article. No abstract available.
References
-
- Worldometer. COVID-19 Coronavirus Pandemic 2020. Available at https://www.worldometers.info/coronavirus/.
-
- Mayoclinic. COVID-19 (coronavirus) in babies and children 2020. Available at https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coro....
-
- Health MoP. Coronavirus Disease (COVID-19 2021). Available at https://covid19.moph.gov.qa/EN/Pages/default.aspx.
-
- Badran Set al. (2021) An evidence base for school health policy during the COVID-19 pandemic. Health Behavior and Policy Review 8, 40–47.
-
- Dong Yet al. (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145, 6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous